Sinovac's Healive Selected by Beijing Centers for Diseases Control and Prevention

Sinovac Biotech Ltd., a leading provider of vaccines in China, announced that it has received confirmation from Beijing Medicine Bidding Center that Sinovac’s hepatitis A vaccine Healive was selected by the Beijing Centers for Diseases Control and Prevention (BJ CDC) pursuant to its tender process.
Yahoo! Finance